MRSN — Mersana Therapeutics Share News
0.000.00%
Last trade - 00:00- $145.16m
- $88.77m
- $40.50m
Mersana soars on Day One's $285 mln buyout deal
U.S. STOCKS ON THE MOVE-Albemarle, DoorDash, Dillard's
Brief: Day One Biopharmaceuticals to Acquire Mersana Therapeutics
U.S. STOCKS ON THE MOVE-Gold miners, Cisco, Silver miners
Mersana soars on Day One's $285 mln buyout deal
U.S. RESEARCH ROUNDUP-U.S. RESEARCH ROUNDUP: Air Products, Biogen and JLL
Mersana Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Mersana Therapeutics Inc expected to post a loss of $3.93 a share - Earnings Preview
Mersana Therapeutics Inc expected to post a loss of $3.93 a share - Earnings Preview
Mersana Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Mersana Therapeutics Q1 EPS USD -0.19
Mersana Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Leidos, Gartner, EVgo
U.S. STOCKS ON THE MOVE-Duke Energy, Leidos, Gartner
U.S. STOCKS ON THE MOVE-Datadog, Marriott, IQVIA
Mersana Therapeutics announces restructuring plans; shares fall
Mersana Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Mersana Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Mersana Therapeutics Receives Nasdaq Non-Compliance Notice